No fault vaccine injury compensation after COVID-19: A systematic literature review and proposed typology
Abstract
The COVID-19 pandemic brought about a unique and rapid period of global vaccine innovation. It revealed structural challenges not only in global vaccine affordability and distribution but in the liability and indemnity structures that can both impede access and affect fair outcomes for the small number of people who suffer severe side effects. This review examines vaccine injury and compensation mechanisms, including no-fault compensation schemes, aimed at addressing both the liability and indemnity concerns of developers and the compensation due those suffering severe side effects. The ultimate aim of the review is to provide a classification of systems for those countries that are considering adopting NFCS as part of their broader public health readiness and preparedness strategies.
Fields of Study & Subjects
Vaccine Coverage and Hesitancy
SARS-CoV-2 and COVID-19 Research
Retinal and Optic Conditions
Publication details
- Journal / source
- Human Vaccines & Immunotherapeutics
- Publisher
- Informa UK Limited
- Volume
- 22
- Issue
- 1
- Pages
- 2620849–2620849
- Publication date
- 2 February 2026
- Language
- EN